Aktienkurs
0.93
Täglich Wechseln
0.02 2.44%
Monatlich
-2.44%
Jährlich
-10.81%
Q2 Prognose
0.88




Bruttoergebnis Vom Umsatz Veränderung Datum
Abbott USD 6.54B 625M 2025-12
Avanos Medical USD 86M 0 2025-12
Baxter International USD 577M 373M 2025-12
Cerus USD 33.33M 8.66M 2024-12
Fresenius Medical Care EUR 1.39B 147M 2025-12
Haemonetics USD 202.39M 7.64M 2025-12
Merit Medical Systems USD 195.35M 8.94M 2025-12
Neogen USD 99M 7.7M 2025-12
Omeros USD -33.16M 18.52M 2024-06
OraSure Technologies USD 11.34M 435K 2025-12
Quidel USD 274.8M 1.01B 2025-12
Rockwell Medical USD 4.55M 1.49M 2024-06
Sanofi EUR 8.45B 1.31B 2025-12
STAAR Surgical USD 43.74M 34.13M 2025-12
Utah Medical Products USD 5.8M 450K 2024-09